BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11977979)

  • 1. Truncation of c-fes via gene targeting results in embryonic lethality and hyperproliferation of hematopoietic cells.
    Hackenmiller R; Simon MC
    Dev Biol; 2002 May; 245(2):255-69. PubMed ID: 11977979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
    Rogers JA; Cheng HY; Smithgall TE
    Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
    Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
    Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-fes expression in ontogenetic development and hematopoietic differentiation.
    Carè A; Mattia G; Montesoro E; Parolini I; Russo G; Colombo MP; Peschle C
    Oncogene; 1994 Mar; 9(3):739-47. PubMed ID: 8108116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of c-Fes tyrosine kinase activity by coiled-coil and SH2 domains: analysis with Saccharomyces cerevisiae.
    Takashima Y; Delfino FJ; Engen JR; Superti-Furga G; Smithgall TE
    Biochemistry; 2003 Apr; 42(12):3567-74. PubMed ID: 12653561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Fes kinase activity in myeloid cell growth and differentiation.
    Yates KE; Crooks GM; Gasson JC
    Stem Cells; 1996 Nov; 14(6):714-24. PubMed ID: 8948028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSH2: a novel SH2 domain-containing adapter protein involved in tyrosine kinase signaling in hematopoietic cells.
    Oda T; Muramatsu MA; Isogai T; Masuho Y; Asano S; Yamashita T
    Biochem Biophys Res Commun; 2001 Nov; 288(5):1078-86. PubMed ID: 11700021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Stat activation, hematopoietic homeostasis, and innate immunity in c-fes-/- mice.
    Hackenmiller R; Kim J; Feldman RA; Simon MC
    Immunity; 2000 Sep; 13(3):397-407. PubMed ID: 11021537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation.
    Tagliafico E; Siena M; Zanocco-Marani T; Manfredini R; Tenedini E; Montanari M; Grande A; Ferrari S
    Oncogene; 2003 Mar; 22(11):1712-23. PubMed ID: 12642874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and structural analysis of murine c-fes cDNA clones.
    Wilks AF; Kurban RR
    Oncogene; 1988 Sep; 3(3):289-94. PubMed ID: 3060793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.
    Lionberger JM; Smithgall TE
    Cancer Res; 2000 Feb; 60(4):1097-103. PubMed ID: 10706130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human c-FES is a nuclear tyrosine kinase.
    Yates KE; Lynch MR; Wong SG; Slamon DJ; Gasson JC
    Oncogene; 1995 Mar; 10(6):1239-42. PubMed ID: 7700650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of c-Fes in normal and neoplastic hematopoiesis.
    Yates KE; Gasson JC
    Stem Cells; 1996 Jan; 14(1):117-23. PubMed ID: 8820957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
    Schuringa JJ; Wu K; Morrone G; Moore MA
    Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains.
    Cheng H; Rogers JA; Dunham NA; Smithgall TE
    Mol Cell Biol; 1999 Dec; 19(12):8335-43. PubMed ID: 10567558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation.
    Ferrari S; Manfredini R; Tagliafico E; Grande A; Barbieri D; Balestri R; Pizzanelli M; Zucchini P; Citro G; Zupi G
    Leukemia; 1994 Apr; 8 Suppl 1():S91-4. PubMed ID: 8152313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The c-Fes family of protein-tyrosine kinases.
    Smithgall TE; Rogers JA; Peters KL; Li J; Briggs SD; Lionberger JM; Cheng H; Shibata A; Scholtz B; Schreiner S; Dunham N
    Crit Rev Oncog; 1998; 9(1):43-62. PubMed ID: 9754447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated Fps/Fes tyrosine kinase regulates erythroid differentiation and survival.
    Sangrar W; Gao Y; Bates B; Zirngibl R; Greer PA
    Exp Hematol; 2004 Oct; 32(10):935-45. PubMed ID: 15504549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human c-Fes tyrosine kinase binds tubulin and microtubules through separate domains and promotes microtubule assembly.
    Laurent CE; Delfino FJ; Cheng HY; Smithgall TE
    Mol Cell Biol; 2004 Nov; 24(21):9351-8. PubMed ID: 15485904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncation of the Mll gene in exon 5 by gene targeting leads to early preimplantation lethality of homozygous embryos.
    Ayton P; Sneddon SF; Palmer DB; Rosewell IR; Owen MJ; Young B; Presley R; Subramanian V
    Genesis; 2001 Aug; 30(4):201-12. PubMed ID: 11536426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.